Sculptor Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,000
Closed -$32.2K 492
2023
Q2
$32.2K Buy
+13,000
New +$25.6K ﹤0.01% 306
2022
Q1
Sell
-125,000
Closed -$256K 1393
2021
Q4
$256K Buy
+125,000
New +$191K ﹤0.01% 823

Sculptor Capital's ROIVW Position: Q3 2023 in Review

Sculptor Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 13,000 shares — an estimated $32.2K sold.

Sculptor Capital first reported a position in ROIVW in Q4 2021 and held it in 2 quarters. The position peaked at $256K in Q4 2021. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Sculptor Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Sculptor Capital sold 13,000 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $32.2K.
  • Sculptor Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 2 quarters.
  • Sculptor Capital's Roivant Sciences Ltd. Warrant position peaked at $256K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Sculptor Capital's 13F filing for Q3 2023, filed 14 Nov 2023.